Clincosm LogoSign in Get a demo

hematologic malignancy

Showing NaN - NaN of 20
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Hematologic Malignancy Trial in Boston (PATH-C)

Not yet recruiting
  • Hematologic Malignancy
  • PATH-C
  • Boston, Massachusetts
    Dana Farber Cancer Institute
Nov 23, 2023

Hematologic Cancer, Hematologic Malignancy Trial in Boston (CBT for Fatigue, Usual Care)

Not yet recruiting
  • Hematologic Cancer
  • Hematologic Malignancy
  • CBT for Fatigue
  • Usual Care
  • Boston, Massachusetts
    Massachusetts General Hospital Cancer Center
Feb 3, 2023

Bone Marrow Transplant Complications, Hematologic Malignancy Trial in Boston (CARE Application, Usual Care)

Not yet recruiting
  • Bone Marrow Transplant Complications
  • Hematologic Malignancy
  • CARE Application
  • Usual Care
  • Boston, Massachusetts
    Massachusetts General Hospital Cancer Center
Feb 1, 2023

Hematologic Malignancy, Blood Cancer, Lymphoma Trial in Boston (Palliative Care, Usual Care)

Recruiting
  • Hematologic Malignancy
  • +4 more
  • Palliative Care
  • Usual Care
  • Boston, Massachusetts
    Massachusetts General Hospital Cancer Center
Jan 24, 2023

Hematologic Malignancy, CAR-T Cell Therapy Trial in Boston (Educational Video Tool)

Active, not recruiting
  • Hematologic Malignancy
  • CAR-T Cell Therapy
  • Educational Video Tool
  • Boston, Massachusetts
    Massachusetts General Hospital
Jan 24, 2023

Hematologic Malignancy, Hematopoietic/Lymphoid Cancer, Blood Cancer Trial in Boston (Positive Psychology Intervention)

Completed
Has Results
  • Hematologic Malignancy
  • +2 more
  • Positive Psychology Intervention
  • Boston, Massachusetts
    Dana Farber Cancer Institute
Nov 14, 2022

CD19 Expressing Malignancies, Hematologic Malignancy Trial in United States (PBCAR19B)

Recruiting
  • CD19 Expressing Malignancies
  • Hematologic Malignancy
  • PBCAR19B
  • Gilbert, Arizona
  • +6 more
Nov 8, 2022

Hematologic Malignancy Trial in Boston (Home Transfusion Program Components)

Not yet recruiting
  • Hematologic Malignancy
  • Home Transfusion Program Components
  • Boston, Massachusetts
    Dana-Farber Cancer Institute
Aug 18, 2022

Hematologic Malignancy, AML, ALL Trial in Australia, United States (Tagraxofusp, Fludarabine, Cytarabine)

Not yet recruiting
  • Hematologic Malignancy
  • +10 more
  • Los Angeles, California
  • +28 more
Jul 26, 2022

Cancer Risk, Cancer Predisposition Syndrome, Hereditary Cancer Prediction Trial in Boston (Samples)

Not yet recruiting
  • Cancer Risk
  • +30 more
  • Samples
  • Boston, Massachusetts
    Dana Farber Cancer Institute
Jul 14, 2022

Caregiver, Hematologic Malignancy Trial in Boston (Positive Psychology Intervention)

Recruiting
  • Caregiver
  • Hematologic Malignancy
  • Positive Psychology Intervention
  • Boston, Massachusetts
    Dana-Farber Cancer Institute
Mar 7, 2022

Hematologic Malignancy, Hematopoietic/Lymphoid Cancer, Blood Cancer Trial in Boston (Positive Psychology Intervention)

Recruiting
  • Hematologic Malignancy
  • +2 more
  • Positive Psychology Intervention
  • Boston, Massachusetts
    Dana Farber Cancer Institute
Dec 20, 2021

Hematologic Malignancy, Leukemia, Lymphoma Trial in Boston (CAR-37 T cells)

Recruiting
  • Hematologic Malignancy
  • +5 more
  • CAR-37 T cells
  • Boston, Massachusetts
    Massachusetts General Hospital Cancer Center
Oct 28, 2021

Hematologic Malignancy Trial in Boston (PET-MRI, PET-CT)

Recruiting
  • Hematologic Malignancy
  • PET-MRI
  • PET-CT
  • Boston, Massachusetts
    Massachusetts General Hospital
Aug 30, 2021

Hematologic Malignancy Trial in Boston (End of Life (EOL) Care at at Home)

Recruiting
  • Hematologic Malignancy
  • End of Life (EOL) Care at at Home
  • Boston, Massachusetts
    Massachusetts General Hospital Cancer Center
Mar 4, 2021

Hematologic Malignancy, Refractory Lymphoma Trial in Boston (Radiotherapy)

Not yet recruiting
  • Hematologic Malignancy
  • Refractory Lymphoma
  • Radiotherapy
  • Boston, Massachusetts
    Massachusetts General Hospital Cancer Center
Jan 19, 2021

Hematologic Malignancy Trial in Boston (AM4113-N5UT Dino-Lite)

Completed
  • Hematologic Malignancy
  • AM4113-N5UT Dino-Lite
  • Boston, Massachusetts
    Massachusetts General Hospital
Jun 7, 2018

Hematologic Malignancy, Bone Marrow Transplantation, Stem Cell Transplantation Trial in Atlanta, Boston, Worcester (Mindfulness

Completed
  • Hematologic Malignancy
  • +2 more
  • Mindfulness training
  • Nurse education
  • Atlanta, Georgia
  • +2 more
Nov 26, 2013

Hematologic Malignancy Trial in Boston (Infusion of donor dendritic cells, Infusion of donor lymphocytes)

Completed
  • Hematologic Malignancy
  • Infusion of donor dendritic cells
  • Infusion of donor lymphocytes
  • Boston, Massachusetts
  • +1 more
Mar 28, 2012

Hematologic Malignancy, AML, ALL Trial in Boston (CD+8 T cell depletion)

Completed
  • Hematologic Malignancy
  • +6 more
  • CD+8 T cell depletion
  • Boston, Massachusetts
  • +1 more
Mar 15, 2012